Please login to the form below

Not currently logged in
Email:
Password:

outcomes

This page shows the latest outcomes news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Ibrance misses the mark in early breast cancer

Pfizer’s Ibrance misses the mark in early breast cancer

We are disappointed in this outcome. Breast cancer is a leading cause of death around the world and delaying or preventing the development of metastatic disease is a significant unmet need,”

Latest news

  • FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC FDA backs BMS’ Opdivo/Yervoy in first-line NSCLC

    We have come a long way in understanding the role of dual immunotherapy-based approaches in cancer and the potential impact on patients’ long-term outcomes,” said David Carbone, CheckMate -9LA

  • Octapharma cleared to start phase 3 trial of Octagam in COVID-19 Octapharma cleared to start phase 3 trial of Octagam in COVID-19

    Octapharma says respiratory deterioration will be the primary outcome measure in its phase 3 trial, with secondary endpoints including pulmonary function, quality of life, and metabolic factors.

  • The mother of all nudges The mother of all nudges

    Because research shows that people who are better informed about their health status are more likely to have better outcomes. ... Berkman ND, et al. Health Literacy Interventions and Outcomes: An Updated Systematic Review.

  • Q&A: Elizabeth Egan Q&A: Elizabeth Egan

    What’s the best thing about working in healthcare comms? The opportunity to blend science, strategy, creativity and technology to create better patient outcomes across multiple therapy areas.

  • Key emerging trends in digital health Key emerging trends in digital health

    One app, in particular, has been making a real difference in patient outcomes – newly relaunched Constant Therapy, an app designed for people who have had a brain injury or live with ... skills, but also patient outcomes as a result. .

More from news
Approximately 14 fully matching, plus 1,770 partially matching documents found.

Latest Intelligence

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    Roche, for example, is running a phase 3 trial to test whether Actemra improves outcomes by dampening hyperinflammation. ... be punctuated by a string of approvals of drugs that improve outcomes in patients infected with SARSCoV-2.

  • Emerging use cases of blockchain in healthcare and the life sciences

    On the one hand, sensitive data such as patients’ health records and the trial’s outcomes must remain private and secure, and the trial protocol itself must be immutable and transparent.

  • Biopharma and orphan drugs Biopharma and orphan drugs

    Medical treatment for patients has historically been based on two primary elements: the expected outcome for the patient, and the ability of treatment to improve the expected outcome.

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    out of five who received treatment with chloroquine had ‘favourable’ outcomes. ... That caution is supported by another study from China that studied hydroxychloroquine in COVID-19 patients and found that there was no significant differences in

  • Listen, learn, act, adapt Listen, learn, act, adapt

    All too often existing plans are retrofitted to a new strategy, ultimately resulting in the same outcomes because you’ve stuck to the same tactics.

More from intelligence
Approximately 10 fully matching, plus 469 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 64 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 8 fully matching, plus 484 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics